As of 2024-12-11, the EV/EBITDA ratio of Adaptive Biotechnologies Corp (ADPT) is -7.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ADPT's latest enterprise value is 1,084.88 mil USD. ADPT's TTM EBITDA according to its financial statements is -145.33 mil USD. Dividing these 2 quantities gives us the above ADPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 13.4x | 12.4x |
| Forward P/E multiples | 12.7x - 14.7x | 13.8x |
| Fair Price | (13.17) - (13.84) | (13.52) |
| Upside | -296.2% - -306.2% | -301.4% |
| Date | EV/EBITDA |
| 2024-12-06 | -7.02 |
| 2024-12-05 | -6.81 |
| 2024-12-04 | -6.89 |
| 2024-12-03 | -7.05 |
| 2024-12-02 | -7.28 |
| 2024-11-29 | -6.68 |
| 2024-11-27 | -6.47 |
| 2024-11-26 | -6.42 |
| 2024-11-25 | -6.32 |
| 2024-11-22 | -5.41 |
| 2024-11-21 | -5.09 |
| 2024-11-20 | -5.14 |
| 2024-11-19 | -5.20 |
| 2024-11-18 | -5.40 |
| 2024-11-15 | -5.81 |
| 2024-11-14 | -6.32 |
| 2024-11-13 | -6.59 |
| 2024-11-12 | -6.67 |
| 2024-11-11 | -7.24 |
| 2024-11-08 | -6.56 |
| 2024-11-07 | -6.37 |
| 2024-11-06 | -6.49 |
| 2024-11-05 | -6.32 |
| 2024-11-04 | -5.99 |
| 2024-11-01 | -6.04 |
| 2024-10-31 | -5.57 |
| 2024-10-30 | -5.79 |
| 2024-10-29 | -5.43 |
| 2024-10-28 | -5.39 |
| 2024-10-25 | -5.17 |
| 2024-10-24 | -5.24 |
| 2024-10-23 | -5.44 |
| 2024-10-22 | -5.42 |
| 2024-10-21 | -5.27 |
| 2024-10-18 | -5.40 |
| 2024-10-17 | -5.36 |
| 2024-10-16 | -5.53 |
| 2024-10-15 | -5.70 |
| 2024-10-14 | -5.68 |
| 2024-10-11 | -5.67 |
| 2024-10-10 | -5.64 |
| 2024-10-09 | -5.73 |
| 2024-10-08 | -5.98 |
| 2024-10-07 | -6.14 |
| 2024-10-04 | -6.26 |
| 2024-10-03 | -5.79 |
| 2024-10-02 | -5.87 |
| 2024-10-01 | -5.75 |
| 2024-09-30 | -5.85 |
| 2024-09-27 | -5.73 |